Pancreatic Cancer Research

ResearcherUniversity of PaviaActive in the last 2 years

Andrea Pietrabissa

Matched on ORCID iD 0000-0001-9703-7587; OpenAlex author ID A5048081397. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
69
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 3 papers · 2024: 1 paper · 2025: 1 paper

Papers 8

  1. Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA Trial. Co-author DOI 10.1001/jamasurg.2025.4054↗
  2. The value of splenectomy during left-sided pancreatectomy for pancreatic ductal adenocarcinoma: predefined subanalysis in the DIPLOMA randomized trial. Co-author DOI 10.1093/bjs/znae236↗
  3. Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatment. Co-author DOI 10.1016/j.ejso.2022.12.006↗
  4. Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial. Co-author DOI 10.1016/j.lanepe.2023.100673↗
  5. Robot-Assisted Versus Laparoscopic Distal Pancreatectomy in Patients with Resectable Pancreatic Cancer: An International, Retrospective, Cohort Study. Co-author DOI 10.1245/s10434-022-13054-2↗
  6. Laparoscopic versus open extended radical left pancreatectomy for pancreatic ductal adenocarcinoma: an international propensity-score matched study. Co-author DOI 10.1007/s00464-020-08206-y↗
  7. Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA): study protocol for a randomized controlled trial. Co-author DOI 10.1186/s13063-021-05506-z↗
  8. An innovative strategy for the identification and 3D reconstruction of pancreatic cancer from CT images. Last author DOI 10.1007/s13304-016-0394-8↗

Closest collaborators

The 25 strongest of 69 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ugo Boggi · 4 shared papers, 2021–2024 · strength 0.48
  2. Alessandro Zerbi · 3 shared papers, 2023–2024 · strength 0.40
  3. Massimo Falconi · 3 shared papers, 2021–2024 · strength 0.37
  4. Roberto Salvia · 3 shared papers, 2021–2024 · strength 0.37
  5. Tobias Keck · 3 shared papers, 2021–2024 · strength 0.33
  6. Riccardo Casadei · 3 shared papers, 2021–2024 · strength 0.33
  7. Bergþór Björnsson · 3 shared papers, 2021–2024 · strength 0.33
  8. Safi Dokmak · 3 shared papers, 2021–2024 · strength 0.33
  9. Thilo Hackert · 3 shared papers, 2021–2024 · strength 0.33
  10. Giovanni Butturini · 3 shared papers, 2021–2024 · strength 0.33
  11. Bas Groot Koerkamp · 3 shared papers, 2021–2024 · strength 0.33
  12. Marc G. Besselink · 3 shared papers, 2021–2024 · strength 0.33
  13. Mohammad Abu Hilal · 3 shared papers, 2021–2024 · strength 0.33
  14. Izaak Quintus Molenaar · 2 shared papers, 2023–2024 · strength 0.25
  15. Giovanni Carlo Ferrari · 2 shared papers, 2023–2024 · strength 0.25
  16. Patricia Sánchez‐Velázquez · 2 shared papers, 2023–2024 · strength 0.25
  17. Alessandro Esposito · 2 shared papers, 2023–2024 · strength 0.25
  18. Adnan A. Alseidi · 2 shared papers, 2021–2024 · strength 0.22
  19. Maarten Korrel · 2 shared papers, 2021–2024 · strength 0.22
  20. Igor E Khatkov · 2 shared papers, 2021–2024 · strength 0.22
  21. Jony van Hilst · 2 shared papers, 2021–2024 · strength 0.22
  22. Bjørn Edwin · 2 shared papers, 2021–2023 · strength 0.20
  23. Sanne Lof · 2 shared papers, 2021–2023 · strength 0.20
  24. Bilal A. Al-Sarireh · 2 shared papers, 2021–2023 · strength 0.20
  25. Luca Vittorio Gianotti · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.